Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-08-20 Higgons John Duncan Chief Operating Officer Exercise or conversion +10,000 $0.30 $3K 141,835
2015-08-20 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −10,000 275,022
2015-08-18 Cantley Lewis Clayton Jr. Director Sale −2,426 $95.69 $232K 152,706
2015-08-18 Cantley Lewis Clayton Jr. Director Sale −2,426 $95.69 $232K 152,706
2015-08-17 Higgons John Duncan Chief Operating Officer Exercise or conversion +20,000 $0.30 $6K 151,835
2015-08-17 Higgons John Duncan Chief Operating Officer Sale −20,000 $92.24 $1.8M 131,835
2015-08-17 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −20,000 285,022
2015-08-17 Cantley Lewis Clayton Jr. Director Sale −2,426 $94.21 $229K 155,132
2015-08-17 Cantley Lewis Clayton Jr. Director Sale −2,426 $94.18 $228K 155,132
2015-08-10 Biller Scott Chief Scientific Officer Exercise or conversion +5,500 $31.64 $174K 39,570
2015-08-10 Biller Scott Chief Scientific Officer Sale −5,500 $100.00 $550K 34,070
2015-08-10 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −5,500 296,380
2015-08-06 Higgons John Duncan Chief Operating Officer Exercise or conversion +10,000 $0.30 $3K 131,835
2015-08-06 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −10,000 305,022
2015-08-03 Schenkein David P Chief Executive Officer Exercise or conversion +701 $0.30 $212 232,973
2015-08-03 Schenkein David P Chief Executive Officer Exercise or conversion +7,299 $31.64 $231K 240,272
2015-08-03 Schenkein David P Chief Executive Officer Sale −8,000 $110.60 $885K 232,272
2015-08-03 Schenkein David P Chief Executive Officer Exercise or conversion · Stock option (right to buy) −701 878,619
2015-08-03 Schenkein David P Chief Executive Officer Exercise or conversion · Stock option (right to buy) −7,299 871,320
2015-07-23 Goddard Glenn Senior Vice President, Finance Exercise or conversion +1,319 $23.10 $30K 1,319

Page 87 of 93 · 1,853 trades